REDW Stanley Financial Advisors »

Tg Therapeutics shares owned by REDW Stanley Financial Advisors

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by REDW Stanley Financial Advisors from 13F filings

Historical chart of REDW Stanley Financial Advisors investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by REDW Stanley Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by REDW Stanley Financial Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $234k 10k 23.39
2024-06-30 $178k 10k 17.79
2024-03-31 $152k 10k 15.21
2023-12-31 $171k 10k 17.08
2023-09-30 $84k 10k 8.36

More positions owned by REDW Stanley Financial Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
American Centy Etf Tr Us Eqt Etf (AVUS)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Dimensional Etf Trust Us High Profitab (DUHP)
Apple (AAPL)
Ishares Msci Emrg Chn (EMXC)
Vanguard Index Fds Real Estate Etf (VNQ)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Flexshares Tr Hig Yld Vl Etf (HYGV)
Ishares Tr Msci Emg Mkt Etf (EEM)

View all positions for REDW Stanley Financial Advisors

Top funds holding Tg Therapeutics

BlackRock
Vanguard Group
BlackRock
State Street Corporation
Soleus Capital Management
Pictet Asset Management Holding SA
Geode Capital Management
Deep Track Capital
Woodline Partners
Susquehanna International
Opaleye Management
Goldman Sachs Group
Bank of America Corporation
Nuveen Asset Management
Morgan Stanley

View all funds holding Tg Therapeutics